Hint: read it backwards.

Seerave is named for Eva Rees, whose experience fighting metastatic melanoma inspired her husband David to establish the Foundation in 2015.

It is pronounced SEE-rayv.

Seerave aims is to improve cancer patients’ lives by leveraging the symbiosis between the immune system and the microbiome.

Seerave aims to improve cancer patients’s lives by leveraging the symbiosis between the immune system and the microbiome. We do this by supporting collaborative, cross-disciplinary academic endeavors and early-stage ventures that translate scientific insights into novel clinical guidelines and tools.

No.

Yes, we are very much open to collaborating with other philanthropic entities.

Some examples of our collaborations include:

• The Periodic Table of Food Initiative (Website)
• The Cancer Platform (Website)
• Controlled high fiber diet interventions in melanoma patients at MD Anderson (Project link)
• The Melanoma & the Microbiome Workshop (Project link)
• The Microbiota Vault (Website)
• The AIForNutrition project (Website)

No. We support efforts that achieve our goals without regard to political affiliation.

The funding comes from a family endowment. David Rees co-founded the downstream oil company Greenergy, which was sold in May 2017 and the resulting proceeds were bequeathed to Seerave to fund its philanthropic activities.

Yes. Seerave Foundation is a registered NPO under Non-Profit Organisations (Jersey) Law 2008, with registration number NPO-7095.

The Seerave Foundation was incorporated in Jersey on 26 March 2015 as a foundation under the Foundations (Jersey) Law, 2009, as amended, with registration number FD280.

Seerave uses a combination of traditional grant donations for academic researchers as well as equity investments into early-stage start-ups. All of our collaborations are mission-aligned. Our project portfolio is built around international alliances of world-leading institutions, visionary scientists and entrepreneurs.